Literature DB >> 15127317

Episodic ataxia type 1 with distal weakness: a novel manifestation of a potassium channelopathy.

A Klein1, E Boltshauser, J Jen, R W Baloh.   

Abstract

Episodic ataxia type1 (EA1) is an autosomal dominant disorder characterised by episodes of ataxia, dysarthria, tremor and visual disturbances lasting for seconds or minutes, precipitated by physical and emotional stress, startle or sudden movements. In addition there is continuous myokymia. Phenotypic variants such as the combination with epilepsy, shortening of the Achilles tendon in children, transient postural abnormalities in infancy, and a very few patients with longer lasting episodes have been reported. We describe a 10-year-old girl with EA1 who has distal weakness with paresis of the extensors of the feet and prolonged spells of limb stiffness (neuromyotonia) lasting up to 12 hours. A novel single nucleotide change at position 785 T > C that alters a highly conserved residue in the third transmembrane segment of the voltage-gated potassium channel Kv1.1 was found.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15127317     DOI: 10.1055/s-2004-817921

Source DB:  PubMed          Journal:  Neuropediatrics        ISSN: 0174-304X            Impact factor:   1.947


  24 in total

1.  Dominant KCNA2 mutation causes episodic ataxia and pharmacoresponsive epilepsy.

Authors:  Mark A Corbett; Susannah T Bellows; Melody Li; Renée Carroll; Silvana Micallef; Gemma L Carvill; Candace T Myers; Katherine B Howell; Snezana Maljevic; Holger Lerche; Elena V Gazina; Heather C Mefford; Melanie Bahlo; Samuel F Berkovic; Steven Petrou; Ingrid E Scheffer; Jozef Gecz
Journal:  Neurology       Date:  2016-10-12       Impact factor: 9.910

Review 2.  The Clinical Spectrum of Autosomal-Dominant Episodic Ataxias.

Authors:  Stefan Kipfer; Michael Strupp
Journal:  Mov Disord Clin Pract       Date:  2014-07-28

Review 3.  Mutational consequences of aberrant ion channels in neurological disorders.

Authors:  Dhiraj Kumar; Rashmi K Ambasta; Pravir Kumar
Journal:  J Membr Biol       Date:  2014-08-14       Impact factor: 1.843

4.  Functional analysis of a novel potassium channel (KCNA1) mutation in hereditary myokymia.

Authors:  Haijun Chen; Christian von Hehn; Leonard K Kaczmarek; Laura R Ment; Barbara R Pober; Fuki M Hisama
Journal:  Neurogenetics       Date:  2006-11-29       Impact factor: 2.660

5.  Whole-exome sequencing as a diagnostic tool in a family with episodic ataxia type 1.

Authors:  Pawel Tacik; Kimberly J Guthrie; Audrey J Strongosky; Daniel F Broderick; Douglas L Riegert-Johnson; Sha Tang; Dima El-Khechen; Alexander S Parker; Owen A Ross; Zbigniew K Wszolek
Journal:  Mayo Clin Proc       Date:  2015-02-03       Impact factor: 7.616

Review 6.  Voltage-gated potassium channels at the crossroads of neuronal function, ischemic tolerance, and neurodegeneration.

Authors:  Niyathi Hegde Shah; Elias Aizenman
Journal:  Transl Stroke Res       Date:  2013-11-19       Impact factor: 6.829

7.  Functional analysis of the Kv1.1 N255D mutation associated with autosomal dominant hypomagnesemia.

Authors:  Jenny van der Wijst; Bob Glaudemans; Hanka Venselaar; Anil V Nair; Anna-Lena Forst; Joost G J Hoenderop; René J M Bindels
Journal:  J Biol Chem       Date:  2009-11-10       Impact factor: 5.157

8.  Kv4.2 knockout mice demonstrate increased susceptibility to convulsant stimulation.

Authors:  L Forbes S Barnwell; Joaquin N Lugo; Wai L Lee; Sarah E Willis; Shira J Gertz; Richard A Hrachovy; Anne E Anderson
Journal:  Epilepsia       Date:  2009-05-11       Impact factor: 5.864

9.  Identification of candidate genes for familial early-onset essential tremor.

Authors:  Xinmin Liu; Nora Hernandez; Sergey Kisselev; Aris Floratos; Ashley Sawle; Iuliana Ionita-Laza; Ruth Ottman; Elan D Louis; Lorraine N Clark
Journal:  Eur J Hum Genet       Date:  2015-10-28       Impact factor: 4.246

10.  A missense mutation in the Kv1.1 voltage-gated potassium channel-encoding gene KCNA1 is linked to human autosomal dominant hypomagnesemia.

Authors:  Bob Glaudemans; Jenny van der Wijst; Rosana H Scola; Paulo J Lorenzoni; Angelien Heister; Annemiete W van der Kemp; Nine V Knoers; Joost G Hoenderop; René J Bindels
Journal:  J Clin Invest       Date:  2009-03-23       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.